Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
Search
Close this search box.
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
Menu
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Trop2 dependent and independent mechanisms of self-renewal in human cancer stem cells

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Progress from our group and others has led to the identification of normal prostate tissue stem cells and the definition of important signaling pathways that regulate their growth and maintenance.…

Continue ReadingTrop2 dependent and independent mechanisms of self-renewal in human cancer stem cells

Prostaglandin pathway regulation of self-renwal in hematopoietic and leukemia stem cells

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Leukemias are cancers of the blood cells that result from corruption of the normal controls that regulate blood-forming stem cells. They are serious causes of illness and death, and are…

Continue ReadingProstaglandin pathway regulation of self-renwal in hematopoietic and leukemia stem cells

Genetic Re-programming of Stem Cells to Fight Cancer

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Science has made great progress in the treatment of certain cancers with targeted and combination therapies, yet prolonged remissions or cures are rare because most cancer therapies only inhibit cell…

Continue ReadingGenetic Re-programming of Stem Cells to Fight Cancer

Targeting glioma cancer stem cells with receptor-engineered self-renewing memory T cells

  • Post author:
  • Post published:May 20, 2025
  • Post category:

While current treatment strategies for high-grade glioma can yield short term benefits, their inability to eradicate the highly tumorigenic cancer stem cell population results in disease recurrence in the vast…

Continue ReadingTargeting glioma cancer stem cells with receptor-engineered self-renewing memory T cells

Stem Cell Gene Therapy for HIV in AIDS Lymphoma Patients

  • Post author:
  • Post published:May 20, 2025
  • Post category:

The Human Immunodeficiency Virus (HIV) is still a major health problem. In both developed and underdeveloped nations, millions of people are infected with this virus. HIV infects cells of the…

Continue ReadingStem Cell Gene Therapy for HIV in AIDS Lymphoma Patients

Recombinant Bispecific Antibody Targeting Cancer Stem Cells for the Therapy of Glioblastoma

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Glioblastoma multiforme is the most prevalent and aggressive type of brain tumor, and devastating to any patient unfortunate enough to receive its diagnosis. As the most populous state in the…

Continue ReadingRecombinant Bispecific Antibody Targeting Cancer Stem Cells for the Therapy of Glioblastoma

Anti-Notch1, OMP-52M51: A New Cancer Therapeutic to Reduce CSC Frequency

  • Post author:
  • Post published:May 20, 2025
  • Post category:

A important benefit of the tremendous progress in stem cell research has been the recognition that stem cell pathways are frequently re-activated in cancer cells conferring stem cell-like properties on…

Continue ReadingAnti-Notch1, OMP-52M51: A New Cancer Therapeutic to Reduce CSC Frequency

Genetic Re-programming of Stem Cells to Fight Cancer

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Science has made great progress in the treatment of certain cancers with targeted and combination therapies, yet prolonged remissions or cures are rare because most cancer therapies only inhibit cell…

Continue ReadingGenetic Re-programming of Stem Cells to Fight Cancer

Stem cell-based carriers for RCR vector delivery to glioblastoma

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Modified viruses can be used to infect tumor cells and alter the tumor cell to make anti-tumor proteins. Most researchers use virus that can infect and modify the tumor cell…

Continue ReadingStem cell-based carriers for RCR vector delivery to glioblastoma

Dual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Leukemia is the most frequent form of cancer in children and teenagers, but is also common in adults. Chemotherapy has vastly improved the outcome of leukemia over the past four…

Continue ReadingDual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication
  • Go to the previous page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us